|
1
|
Cerhan JR and Habermann TM: Epidemiology
of marginal zone. Lymphoma. Ann Lymphoma. 5:2021. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chuang SS, Chen SW, Chang ST and Kuo YT:
Lymphoma in Taiwan: Review of 1347 neoplasms from a single
institution according to the 2016 Revision of the World Health
Organization Classification. J Formos Med Assoc. 116:620–625. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
El-Fattah MA: Non-hodgkin lymphoma of the
liver: A US population-based analysis. J Clin Transl Hepatol.
5:83–91. 2017.PubMed/NCBI
|
|
4
|
Zucca E, Arcaini L, Buske C, Johnson PW,
Ponzoni M, Raderer M, Ricardi U, Salar A, Stamatopoulos K,
Thieblemont C, et al: Marginal zone lymphomas: ESMO clinical
practice guidelines. Ann Oncol. 31:17–29. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Routsias JG, Goules JD, Charalampakis G,
Tzima S, Papageorgiou A and Voulgarelis M: Malignant lymphoma in
primary Sjögren's syndrome: An update on the pathogenesis and
treatment. Semin. Arthritis Rheum. 43:178–186. 2013.PubMed/NCBI
|
|
6
|
Smith T and Cunningham-Rundles C: Lymphoid
malignancy in common variable immune-deficiency in a single-center
cohort. Eur J Haematol. 107:503–516. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Amin MB, Edge SB, Greene FL, Byrd DR,
Brookland RK, Washington MK, Gershenwald JE, Compton CC, Hess KR,
Sullivan DC, et al: AJCC Cancer Staging Manual. 8th Edition.
Springer Cham; Switzerland: pp. 9542017
|
|
8
|
U.S. Department of Health and Human
Services, . Common Terminology Criteria for Adverse Events (CTCAE).
Version 4.0. https://evs.nci.nih.gov/ftp1/CTCAE/CTCAE_4.03/Archive/CTCAE_4.0_2009-05-29_QuickReference_8.5×11.pdfFebruary
12–2025
|
|
9
|
Meignan M, Gallamini A, Meignan M,
Gallamini A and Haioun C: Report on the first international
workshop on interim-PET-scan in lymphoma. Leuk Lymphoma.
50:1257–1260. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zucca E, Bertoni F, Vannata B and Cavalli
F: Emerging role of infectious etiologies in the pathogenesis of
marginal zone B-cell lymphomas. Clin Cancer Res. 20:5207–5216.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Betianu CI, Dima A and Pavaloiu G: Primary
hepatic mucosa-associated lymphoid tissue lymphoma in a patient
with no chronic liver disease: Case report. J Radiol Case Rep.
12:715–719. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Bao C, Wei J, Zhao X, Lin L, Chen D, Liu
K, Qian W, Anas JM and Zhao K: Prognostic value of
fluorine-18-fluorodeoxyglucose positron emission
tomography/computed tomography in primary hepatic mucosa-associated
lymphoid tissue lymphoma: A case report and review of the
literature. Medicine (Baltimore). 97:98772018. View Article : Google Scholar
|
|
13
|
Choi S, Kim JH, Kim K, Kim M, Choi HJ, Kim
YM, Suh JH, Seo MJ and Cha HJ: Primary hepatic extranodal marginal
zone lymphoma of mucosa-associated lymphoid tissue. J Pathol Transl
Med. 54:340–345. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Okura K, Seo S, Shimizu H, Nishino H, Yoh
T, Fukumitsu K, Ishii T, Hata K, Haga H and Hatano E: Primary
hepatic extranodal marginal zone B-cell mucosa-associated lymphoid
tissue lymphoma treated by laparoscopic partial hepatectomy: A case
report. Surg Case Rep. 9:292023. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Xu Z, Pang C, Sui J and Gao Z: A case of
primary hepatic extranodal marginal zone B-cell mucosa-associated
lymphoid tissue (MALT) lymphoma treated by radiofrequency ablation
(RFA), and a literature review. J Int Med Res. 49:300060521999539.
2021.
|
|
16
|
Yamashita Y, Joshita S, Kobayashi H,
Wakabayashi SI, Sugiura A, Yamazaki T and Umemura T: Primary
hepatic extranodal marginal zone lymphoma of mucosa-associated
lymphoid tissue in a patient with chronic hepatitis B virus
infection: Case report and summary of the literature. Medicina
(Kaunas). 57:2802021. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Xie H, Lv J, Ji Y, Du X and Yang X:
Primary hepatic mucosa-associated lymphoid tissue lymphoma.
Medicine (Baltimore). 98:e150342019. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Koh HD, Choi JW, Kim EK, Park S, Kim MJ
and Lee CK: Primary hepatic mucosa-associated lymphoid tissue
lymphoma mimicking hepatocellular carcinoma in a patient with
chronic hepatitis B: A case report. J Int Med Res.
51:30006052311543992023. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Liu C, Liu Y, Zhang J, Chai Y, Lu B and
Tang H: Primary hepatic mucosa-associated lymphoid tissue lymphoma
complicated with atrial fibrillation: A case report and literature
review. Medicine (Baltimore). 103:e369262024. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Benson AB III, D'Angelica MI, Abrams T,
Ahmed A, Anaya DA, Anders R, Are C, Bachini M, Baker M, Binder D,
et al: NCCN clinical practice guidelines in oncology:
Hepatocellular carcinoma. National Comprehensive Cancer Network,
Version. 1:512024.
|
|
21
|
Zelenetz AD, Gordon LI, Abramson JS,
Advani RH, Andreadis B, Bartlett NL, Budde LE, Caimi PF, Chang JE,
Christian B, et al: NCCN clinical practice guidelines in oncology:
B-cell lymphomas. National Comprehensive Cancer Network, Version.
2:1442024.
|
|
22
|
Pinnix CC, Dabaja BS, Gunther JR, Fang PQ,
Wu SY, Nastoupil LJ, Strati P, Nair R, Ahmed S, Steiner R, et al:
Response-adapted ultralow-dose radiation therapy for orbital
indolent B-Cell lymphoma A phase 2 nonrandomized controlled trial.
JAMA Oncol. 10:1195–1203. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yahalom J, Illidge T, Specht L, Hoppe RT,
Li YX, Tsang R and Wirth A; International Lymphoma Radiation
Oncology Group, : Modern radiation therapy for extranodal
lymphomas: Field and dose guidelines from the international
lymphoma radiation oncology group. Int J Radiat Oncol Biol Phys.
92:11–31. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Toesca DAS, Ibragimov B, Koong AJ, Xing L,
Koong AC and Chang DT: Strategies for prediction and mitigation of
radiation-induced liver toxicity. J Radiat Res. 59:40–49. 2018.
View Article : Google Scholar
|
|
25
|
Toesca DA, Osmundson EC, Eyben RV, Shaffer
JL, Lu P, Koong AC and Chang DT: Central liver toxicity after SBRT:
An expanded analysis and predictive nomogram. Radiother Oncol.
122:130–136. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Katano A and Yamashita H: Definitive
radiotherapy for stage I gastric mucosa-associated lymphoid tissue
lymphoma: A retrospective cohort of unique-dose administration of
30 Gy in 15 fractions and analysis of remission duration. World J
Oncol. 15:506–510. 2024. View Article : Google Scholar : PubMed/NCBI
|
